Latest Response Evaluation Criteria in Solid Tumors Stories
-New Viewer provides Astonishing image quality and flexibility- CAMBRIDGE, Mass., Nov. 20, 2014 /PRNewswire/ -- AZE Technology today announces the U.S.
Based on encouraging progression-free survival data, Lpath extends the study to a second cohort and considers additional proof-of-concept studies SAN DIEGO, July 24, 2014 /PRNewswire/
NEW YORK, June 25, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board
Company Reported Positive Preliminary Responses in Phase I/II Trial Patients; Feuerstein Falsely Claims There Is No Positive Trial Information BETHESDA, Md., May
CAMBRIDGE, Mass., Jan.
Data from a number of clinical trials presented today at the International Liver Congress™ 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma (HCC).
Cancer immunotherapy calls for revised clinical endpoints that differ from those used for chemotherapy.
Advanced imaging technologies that promise to improve the development of effective drugs to treat lung cancer are the focus of the current special issue of Optics Express (http://www.opticsinfobase.org/oe), an open-access journal published by the Optical Society (OSA).
The first, formal revision of specific guidelines, known as RECIST, used by clinicians to measure tumor size and response to treatment, has been published today (Tuesday 20 January) in a special issue of the European Journal of Cancer.
- Inward knowledge; understanding; conscience.